Compacted	O
Multiparticulate	B:C0085104
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	B:C0009368
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	B:C0085104
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	B:C0022635
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	B:C0013227
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	B:C0009368
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	B:C0085104
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	B:C0013227
tablets	I:C0013227
and	O
pellet	O
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

Compacted	O
Multiparticulate	O
Systems	I:C0085104
for	O
Colon	O
-	O
Specific	O
Delivery	O
of	O
Ketoprofen	O
Pellet	O
-	O
containing	O
tablets	O
for	O
colon	O
-	O
specific	O
drug	O
delivery	I:C0085104
present	O
higher	O
targeting	O
efficiency	O
and	O
lower	O
costs	O
when	O
compared	O
with	O
monolithic	O
tablets	I:C0013227
and	O
pellet	B:C0006935
-	I:C0006935
filled	I:C0006935
capsules	I:C0006935
,	O
respectively	O
.	O

In	O
this	O
study	O
,	O
pellets	B:C0993610
containing	O
ketoprofen	O
were	O
coated	O
with	O
different	O
acrylic	O
polymers	I:C0101309
and	O
submitted	O
to	O
compaction	O
.	O

In	O
this	O
study	O
,	O
pellets	O
containing	O
ketoprofen	B:C0022635
were	O
coated	O
with	O
different	O
acrylic	O
polymers	I:C0101309
and	O
submitted	O
to	O
compaction	O
.	O

In	O
this	O
study	O
,	O
pellets	O
containing	O
ketoprofen	O
were	O
coated	O
with	O
different	O
acrylic	B:C0101309
polymers	I:C0101309
and	O
submitted	O
to	O
compaction	O
.	O

Pellet	B:C0993610
s	O
were	O
prepared	O
via	O
extrusion	O
-	O
spheronization	O
and	O
coated	O
using	O
two	O
acrylic	O
polymers	I:C0101309
(	O
Eudragit®	O
FS	I:C0961486
30	I:C0961486
D	I:C0961486
and	O
Opadry	O
®	O
94	O
k28327	O
,	O
PMMA	O
and	O
PMA	O
,	O
respectively	O
)	O
.	O

Pellet	O
s	O
were	O
prepared	O
via	O
extrusion	O
-	O
spheronization	O
and	O
coated	O
using	O
two	O
acrylic	B:C0101309
polymers	I:C0101309
(	O
Eudragit®	O
FS	I:C0961486
30	I:C0961486
D	I:C0961486
and	O
Opadry	O
®	O
94	O
k28327	O
,	O
PMMA	O
and	O
PMA	O
,	O
respectively	O
)	O
.	O

Pellet	O
s	O
were	O
prepared	O
via	O
extrusion	O
-	O
spheronization	O
and	O
coated	O
using	O
two	O
acrylic	O
polymers	I:C0101309
(	O
Eudragit®	B:C0961486
FS	I:C0961486
30	I:C0961486
D	I:C0961486
and	O
Opadry	O
®	O
94	O
k28327	O
,	O
PMMA	O
and	O
PMA	O
,	O
respectively	O
)	O
.	O

Pellet	O
s	O
were	O
prepared	O
via	O
extrusion	O
-	O
spheronization	O
and	O
coated	O
using	O
two	O
acrylic	O
polymers	I:C0101309
(	O
Eudragit®	O
FS	I:C0961486
30	I:C0961486
D	I:C0961486
and	O
Opadry	O
®	O
94	O
k28327	O
,	O
PMMA	B:C0005533
and	O
PMA	O
,	O
respectively	O
)	O
.	O

Pellet	O
s	O
were	O
prepared	O
via	O
extrusion	O
-	O
spheronization	O
and	O
coated	O
using	O
two	O
acrylic	O
polymers	I:C0101309
(	O
Eudragit®	O
FS	I:C0961486
30	I:C0961486
D	I:C0961486
and	O
Opadry	O
®	O
94	O
k28327	O
,	O
PMMA	O
and	O
PMA	B:C0032521
,	O
respectively	O
)	O
.	O

The	O
resulting	O
pellets	B:C0993610
were	O
mixed	O
with	O
placebo	O
granules	I:C1696465
and	O
compressed	O
in	O
a	O
hydraulic	O
press	O
.	O

The	O
resulting	O
pellets	O
were	O
mixed	O
with	O
placebo	B:C1696465
granules	I:C1696465
and	O
compressed	O
in	O
a	O
hydraulic	O
press	O
.	O

Multiple	O
regression	O
showed	O
that	O
ketoprofen	B:C0022635
release	O
from	O
pellet	O
-	O
containing	O
tablets	O
is	O
predominantly	O
influenced	O
by	O
pellet	O
content	O
,	O
hardness	O
,	O
friability	O
,	O
and	O
disintegration	O
time	O
.	O

Multiple	O
regression	O
showed	O
that	O
ketoprofen	O
release	O
from	O
pellet	B:C0993610
-	O
containing	O
tablets	O
is	O
predominantly	O
influenced	O
by	O
pellet	O
content	O
,	O
hardness	O
,	O
friability	O
,	O
and	O
disintegration	O
time	O
.	O

Multiple	O
regression	O
showed	O
that	O
ketoprofen	O
release	O
from	O
pellet	O
-	O
containing	O
tablets	B:C0013227
is	O
predominantly	O
influenced	O
by	O
pellet	O
content	O
,	O
hardness	O
,	O
friability	O
,	O
and	O
disintegration	O
time	O
.	O

Multiple	O
regression	O
showed	O
that	O
ketoprofen	O
release	O
from	O
pellet	O
-	O
containing	O
tablets	O
is	O
predominantly	O
influenced	O
by	O
pellet	B:C0993610
content	O
,	O
hardness	O
,	O
friability	O
,	O
and	O
disintegration	O
time	O
.	O

PMA	B:C0032521
-	O
containing	O
tablets	O
prepared	O
under	O
low	O
compaction	O
force	O
or	O
with	O
low	O
pellet	O
content	O
showed	O
rapid	O
disintegration	O
(	O
<	O
1	O
min	O
)	O
and	O
ketoprofen	O
release	O
similar	O
to	O
those	O
of	O
uncompressed	O
coated	O
pellets	O
(	O
∼30	O
%	O
at	O
360	O
min	O
of	O
experiment	O
)	O
.	O

PMA	O
-	O
containing	O
tablets	B:C0013227
prepared	O
under	O
low	O
compaction	O
force	O
or	O
with	O
low	O
pellet	O
content	O
showed	O
rapid	O
disintegration	O
(	O
<	O
1	O
min	O
)	O
and	O
ketoprofen	O
release	O
similar	O
to	O
those	O
of	O
uncompressed	O
coated	O
pellets	O
(	O
∼30	O
%	O
at	O
360	O
min	O
of	O
experiment	O
)	O
.	O

PMA	O
-	O
containing	O
tablets	O
prepared	O
under	O
low	O
compaction	O
force	O
or	O
with	O
low	O
pellet	B:C0993610
content	O
showed	O
rapid	O
disintegration	O
(	O
<	O
1	O
min	O
)	O
and	O
ketoprofen	O
release	O
similar	O
to	O
those	O
of	O
uncompressed	O
coated	O
pellets	O
(	O
∼30	O
%	O
at	O
360	O
min	O
of	O
experiment	O
)	O
.	O

PMA	O
-	O
containing	O
tablets	O
prepared	O
under	O
low	O
compaction	O
force	O
or	O
with	O
low	O
pellet	O
content	O
showed	O
rapid	O
disintegration	O
(	O
<	O
1	O
min	O
)	O
and	O
ketoprofen	B:C0022635
release	O
similar	O
to	O
those	O
of	O
uncompressed	O
coated	O
pellets	O
(	O
∼30	O
%	O
at	O
360	O
min	O
of	O
experiment	O
)	O
.	O

PMA	O
-	O
containing	O
tablets	O
prepared	O
under	O
low	O
compaction	O
force	O
or	O
with	O
low	O
pellet	O
content	O
showed	O
rapid	O
disintegration	O
(	O
<	O
1	O
min	O
)	O
and	O
ketoprofen	O
release	O
similar	O
to	O
those	O
of	O
uncompressed	O
coated	O
pellets	B:C0993610
(	O
∼30	O
%	O
at	O
360	O
min	O
of	O
experiment	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
PMMA	B:C0005533
-	O
containing	O
tablets	O
showed	O
a	O
higher	O
rupture	O
level	O
,	O
and	O
those	O
prepared	O
with	O
higher	O
pellet	O
content	O
gave	O
rise	O
to	O
a	O
non-disintegrating	O
matrix	O
.	O

On	O
the	O
other	O
hand	O
,	O
PMMA	O
-	O
containing	O
tablets	B:C0013227
showed	O
a	O
higher	O
rupture	O
level	O
,	O
and	O
those	O
prepared	O
with	O
higher	O
pellet	O
content	O
gave	O
rise	O
to	O
a	O
non-disintegrating	O
matrix	O
.	O

On	O
the	O
other	O
hand	O
,	O
PMMA	O
-	O
containing	O
tablets	O
showed	O
a	O
higher	O
rupture	O
level	O
,	O
and	O
those	O
prepared	O
with	O
higher	O
pellet	B:C0993610
content	O
gave	O
rise	O
to	O
a	O
non-disintegrating	O
matrix	O
.	O

Coated	O
pellets	B:C0993610
were	O
shown	O
to	O
be	O
able	O
to	O
target	O
ketoprofen	O
to	O
the	O
colonic	O
region	I:C0009368
.	O

Coated	O
pellets	O
were	O
shown	O
to	O
be	O
able	O
to	O
target	O
ketoprofen	B:C0022635
to	O
the	O
colonic	O
region	I:C0009368
.	O

Coated	O
pellets	O
were	O
shown	O
to	O
be	O
able	O
to	O
target	O
ketoprofen	O
to	O
the	O
colonic	B:C0009368
region	I:C0009368
.	O

Targeting	O
capacity	O
was	O
dependent	O
on	O
the	O
physicochemical	O
characteristics	O
of	O
the	O
tablets	B:C0013227
.	O

